<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01670448</url>
  </required_header>
  <id_info>
    <org_study_id>CE12.231</org_study_id>
    <nct_id>NCT01670448</nct_id>
  </id_info>
  <brief_title>PECBLOCK for the Treatment of Pain After Breast Surgery</brief_title>
  <acronym>PECBLOC</acronym>
  <official_title>The Pectoral Nerve Block (PECBLOCK) for the Treatment of Pain After Breast Cancer Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain after breast cancer surgery could be severe and about 1/3 of patients will develop
      chronic pain. The PECBLOCK is the injection of local anesthetics between the two pectoral
      muscles to block pectoral nerves and intercostal nerves innervating the breast. The aim of
      this study is to evaluate the efficacy of the PECBLOCK performed under echoguidance in minor
      and major breast surgery. The prevention of chronic pain following surgery will also be
      evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score at rest in the recovery room</measure>
    <time_frame>30 min after entering the recovery room or just before morphine administration if needed</time_frame>
    <description>Using a 0-10 verbal numerical scale where 0 is no pain and 10 the worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption in the recovery room</measure>
    <time_frame>in the recovery room before discharge (after 1 h on average))</time_frame>
    <description>When surgery is over and the patient is brought to the recovery room, the total morphine consumption in mg used in the recovery (for pain less than 4/10) is recorded</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Total sufentanil consumption during surgery</measure>
    <time_frame>at the end of surgery (1-2 h on average)</time_frame>
    <description>When surgery is over, 1-2 h on average depending if it is a tumorectomy or a mastectomy, the total sufentanil consumption in micrograms during surgery is recorded.</description>
  </other_outcome>
  <other_outcome>
    <measure>Assess any complication from PECBLOCK</measure>
    <time_frame>first 24 hours post surgery</time_frame>
    <description>Cardiovascular collapse, anaphylactic shock, hematoma, bleeding..?</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Cancer</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>PECBLOCK performed with bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active drug given through PECBLOCK in these patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PECBLOCK performed with NaCl 0.9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo drug given through PECBLOCK in these patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PECBLOCK under echoguidance</intervention_name>
    <description>Performance of block under echography</description>
    <arm_group_label>PECBLOCK performed with bupivacaine</arm_group_label>
    <arm_group_label>PECBLOCK performed with NaCl 0.9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women aged 18-85 yrs old

          -  patients ASA status I-IV

        Exclusion Criteria:

          -  refusal of the PECBLOCK

          -  allergy to a drug used in the protocol (local anesthetic)

          -  patients with chronic pain before the surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jérôme Cros, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Limoges</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Beaulieu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2012</study_first_submitted>
  <study_first_submitted_qc>August 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2012</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Chronic pain prevention</keyword>
  <keyword>Regional anesthesia</keyword>
  <keyword>Mastectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

